Efficacy and safety of tamsulosin for the treatment of non-neurogenic voiding dysfunction in females: A 8-week prospective study

Journal of Korean Medical Science

Volumn 25, Issue 1, 2010, Pages 117-122

  Lee, Kyu Sung ^a   Han, Deok Hyun ^a   Lee, Young Suk ^a   Choo, Myung Soo ^b   Yoo, Tag Keun ^c   Park, Heung Jae ^a   Yoon, Hana ^d   Jeong, Hyeon ^e   Lee, Sun Ju ^f   Kim, Hayoung ^g   Park, Won Hee ^h  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Eulji University School of Medicine   (South Korea)

^d Ewha Womans University School of Medicine   (South Korea)

^e Seoul National University Boramae Hospital   (South Korea)

^f Kyung Hee University College of Medicine   (South Korea)

^g Hallym University   (South Korea)

^h Inha University School of Medicine   (South Korea)

Author keywords

Adrenergic alpha Antagonists; Female; Outcomes Assessment; Urination Disorders

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; SULFONAMIDE; TAMSULOSIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; FEMALE; HOSPITALIZATION; HUMAN; MICTURITION DISORDER; MIDDLE AGED; MULTICENTER STUDY; QUESTIONNAIRE; TREATMENT OUTCOME;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MIDDLE AGED; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SULFONAMIDES; TREATMENT OUTCOME; URINATION DISORDERS;

EID: 77949321931     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.1.117     Document Type: Article

References (20)

1. Groutz A, Blaivas JG. Non-neurogenic female voiding dysfunction. Curr Opin Urol 2002; 12: 311-6.
2. Kessler TM, Studer UE, Burkhard FC. The effect of terazosin on func-tional bladder outlet obstruction in women: a pilot study. J Urol 2006; 176: 1487-92.
3. Pischedda A, Pirozzi Farina F, Madonia M, Cimino S, Morgia G. Use of alpha1-blockers in female functional bladder neck obstruction. Urol Int 2005; 74: 256-61.
4. Yamanishi T, Yasuda K, Kamai T, Tsujii T, Sakakibara R, Uchiya-ma T, Yoshida K. Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of void-ing difficulty in patients with underactive detrusor. Int J Urol 2004; 11: 88-96.
5. Andersson KE, Lepor H, Wyllie MG. Prostatic alpha 1-adrenocep-tors and uroselectivity. Prostate 1997; 30: 202-15.
6. Morita T, Latifpour J, O'Hollaren B, Wheeler MA, Weiss RM. Sex differences in function and distribution of alpha 1-and alpha 2-adre-noceptors in rabbit urethra. Am J Physiol 1987; 252: F1124-8.
7. Nasu K, Moriyama N, Fukasawa R, Tsujimoto G, Tanaka T, Yano J, Kawabe K. Quantification and distribution of alpha1-adrenoceptor subtype mRNAs in human proximal urethra. Br J Pharmacol 1998; 123: 1289-93.
8. Yablonsky F, Riffaud JP, Lacolle JY, Dausse JP. Alpha 1-and alpha 2-adrenoceptors in the smooth muscle of male and female rabbit ure-thra. Eur J Pharmacol 1986; 121: 1-8.
9. Schafer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, Sterling AM, Zinner NR, van Kerrebroeck P. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow stud-ies. Neurourol Urodyn 2002; 21: 261-74.
10. Brookes ST, Donovan JL, Wright M, Jackson S, Abrams P. A scored form of the Bristol Female Lower Urinary Tract Symptoms question-naire: data from a randomized controlled trial of surgery for women with stress incontinence. Am J Obstet Gynecol 2004; 191: 73-82.
11. Blaivas JG, Groutz A. Bladder outlet obstruction nomogram for women with lower urinary tract symptomatology. Neurourol Uro-dyn 2000; 19: 553-64.
12. Gerstenberg TC, Lykkegaard Nielsen M, Lindenberg J. Spastic stri-ated external sphincter syndrome imitating recurrent urinary tract infection in females. Effect of long-term alpha-adrenergic blockade with phenoxybenzamine. Eur Urol 1983; 9: 87-92.
13. Kawabe K, Niijima T. Use of an alpha 1-blocker, YM-12617, in mic-turition difficulty. Urol Int 1987; 42: 280-4.
14. Yoshida O, Takeuchi H, Hida S, Tomoyoshi T, Arai Y, Okada K, Akino H, Isomatsu I, Okabe T, Fukuyama T, Komatsu Y, Fukuya-ma T, Takahashi Y, Nakamura KH, Sanada S, Ueda M, Inoue H, Matsuo M, Watanabe J, Hayashida H, Itokawa Y. Clinical efficacy and safety of long-term administration of YM617 for urinary obstruc-tion of the lower urinary tract. Hinyokika Kiyo 1991; 37: 421-9.
15. Reitz A, Haferkamp A, Kyburz T, Knapp PA, Wefer B, Schurch B. The effect of tamsulosin on the resting tone and the contractile beha-viour of the female urethra: a functional urodynamic study in healthy women. Eur Urol 2004; 46: 235-40.
16. Kumar A, Mandhani A, Gogoi S, Srivastava A. Management of func-tional bladder neck obstruction in women: use of alpha-blockers and pediatric resectoscope for bladder neck incision. J Urol 1999; 162: 2061-5.
17. Akikwala TV, Fleischman N, Nitti VW. Comparison of diagnostic criteria for female bladder outlet obstruction. J Urol 2006; 176: 2093-7.
18. Low BY, Liong ML, Yuen KH, Chee C, Leong WS, Chong WL, Khan NA, Cheah PY, Liong KK. Terazosin therapy for patients with female lower urinary tract symptoms: a randomized, double-blind, placebo controlled trial. J Urol 2008; 179: 1461-9.
19. Pummangura N, Kochakarn W. Efficacy of tamsulosin in the treat-ment of lower urinary tract symptoms (LUTS) in women. Asian J Surg 2007; 30: 131-7.
20. Chang SJ, Chiang IN, Yu HJ. The effectiveness of tamsulosin in treat-ing women with voiding difficulty. Int J Urol 2008; 15: 981-5.